Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age With Mild to Moderate Atopic Dermatitis

NCT00120523 is registered in ClinicalTrials.gov with MEDA Pharma GmbH & Co. KG as lead sponsor.

NCT NCT00120523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00120523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age With Mild to Moderate Atopic Dermatitis
Lead sponsor
MEDA Pharma GmbH & Co. KG
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
October 31, 2010
Enrollment
2,418 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis